{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:36:36Z","timestamp":1760027796812},"reference-count":34,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart"],"published-print":{"date-parts":[[1985,2,1]]},"DOI":"10.1136\/hrt.53.2.208","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T21:46:00Z","timestamp":1190151960000},"page":"208-215","source":"Crossref","is-referenced-by-count":19,"title":["Are the clinical benefits of oral prenalterol in ischaemic heart failure due to beta blockade? A six month randomised double blind comparison with placebo."],"prefix":"10.1136","volume":"53","author":[{"given":"D R","family":"Glover","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C G","family":"Wathen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R G","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M C","family":"Petch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A L","family":"Muir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W A","family":"Littler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0002-8703(81)90736-5","article-title":"Heart failure: pathophysiology and treatment","volume":"102","author":"Braunwald, E.","year":"1980","unstructured":"Braunwald E. Heart failure: pathophysiology and treatment. Am HeartJ 1980; 102: 486-90.","journal-title":"Am HeartJ"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.47.6.1154","article-title":"Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. II Ventriculographic and other correlations","volume":"47","author":"Bruschke, A.V.G.; Proudfit, W.L.; FM, Jr, Sones","year":"1973","unstructured":"Bruschke AVG, Proudfit WL, Sones FM Jr. Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5-9 years. II Ventriculographic and other correlations. Circulation 1973; 47: 1154-63.","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1001\/archinte.1981.00340010020005","article-title":"Digitalis in cardiac failure. Do benefits justify risks?","volume":"141","author":"Selzer, A.","year":"1981","unstructured":"Selzer A. Digitalis in cardiac failure. Do benefits justify risks? Arch Intern Med 1981; 141: 18-9.","journal-title":"Arch Intern Med"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0140-6736(79)91002-X","article-title":"Is maintenance digoxin necessary in patients with sinus rhythm?","volume":"i:","author":"Johnston, G.D.; McDevitt, D.G.","year":"1979","unstructured":"Johnston GD, McDevitt DG. Is maintenance digoxin necessary in patients with sinus rhythm? Lancet 1979; i: 567-70.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1136\/thx.34.2.147","article-title":"Digoxin for heart failure in sinus rhythm","volume":"34","author":"MC, S.Petch","year":"1979","unstructured":"S Petch MC. Digoxin for heart failure in sinus rhythm. Thorax 1979; 34: 147-9.","journal-title":"Thorax"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1136\/bmj.284.6328.1526","article-title":"Evaluation of digitalis in cardiac failure","volume":"284","author":"Murray, R.G.; Tweddel, A.C.; Martin, W.; Pearson, D.; Hutton, I.; Lawrie, T.D.V.","year":"1982","unstructured":"Murray RG, Tweddel AC, Martin W, Pearson D, Hutton I, Lawrie TDV. Evaluation of digitalis in cardiac failure. Br Med J 1982; 284: 1526-8.","journal-title":"Br Med J"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJM198012183032503","article-title":"Long term digitalis therapy improves left ventricular function in heart failure","volume":"303","author":"Arnold, S.B.; Byrd, R.C.; Meister, W.","year":"1980","unstructured":"Arnold SB, Byrd RC, Meister W, et al. Long term digitalis therapy improves left ventricular function in heart failure. N Engl J Med 1980; 303: 1443-8.","journal-title":"N Engl J Med"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198203253061202","article-title":"Heart failure in outpatients: a randomized trial of digoxin versus placebo","volume":"306","author":"Lee, D.C.; Johnson, R.A.; Bingham, J.B.","year":"1982","unstructured":"Lee DC, Johnson RA, Bingham JB, et al. Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med 1982; 306: 699-705.","journal-title":"N Engl J Med"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1146\/annurev.pa.20.040180.002355","article-title":"Vasodilator therapy for chronic heart failure","volume":"20","author":"Chatterjee, K.; Parmley, W.W.","year":"1980","unstructured":"Chatterjee K, Parmley WW. Vasodilator therapy for chronic heart failure. Ann Rev Pharmacol Toxicol 1980; 20: 475-512.","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1136\/bmj.284.6318.765","article-title":"Vasodilators in heart failure","volume":"284","author":"Breckenridge, A.","year":"1982","unstructured":"Breckenridge A. Vasodilators in heart failure. Br Med J 1982; 284: 756-6.","journal-title":"Br Med J"},{"key":"ref_11","first-page":"1098104","article-title":"Amrinone: a new non-glycosidic non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man","volume":"59","author":"LeJemtel, T.H.; Keung, E.; Sonnenblick, E.H.","year":"1979","unstructured":"LeJemtel TH, Keung E, Sonnenblick EH, et al. Amrinone: a new non-glycosidic non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation 1979; 59: 1098104.","journal-title":"Circulation"},{"key":"ref_12","first-page":"77","article-title":"Sympathomimetics in heart failure","volume-title":"Drug Ther Bull","volume":"20","author":"Anonymous","year":"1982","unstructured":"Anonymous. Sympathomimetics in heart failure. Drug Ther Bull 1982; 20: 77-9."},{"key":"ref_13","first-page":"10634","article-title":"Beta agonists and heart failure","volume":"ii:","author":"Anonymous","year":"1983","unstructured":"Anonymous. Beta agonists and heart failure. Lancet 1983; ii: 10634.","journal-title":"Lancet"},{"key":"ref_14","first-page":"135","article-title":"Clinical studies with beta2 adrenoceptor agonist in heart failure. Eur HeartJ'","volume":"3","author":"true","year":"1982","unstructured":"Dawson JR, Bayliss J, Norrell MS, et al. Clinical studies with beta2 adrenoceptor agonist in heart failure. Eur HeartJ' 1982; 3 (suppl D): 135-41."},{"key":"ref_15","first-page":"9","article-title":"Basic pharmacological properties of prenalterol","volume":"659","author":"Mattsson, H.; Hedberg, A.; Carlsson, E.","year":"1982","unstructured":"Mattsson H, Hedberg A, Carlsson E. Basic pharmacological properties of prenalterol. Acta Med Scand 1982; 659 (suppl): 9-37.","journal-title":"Acta Med Scand"},{"key":"ref_16","first-page":"584","article-title":"Hemodynamic effects of Corwin (ICI 118, 587), a new cardioselective beta-adrenoceptor partial agonist","volume":"7","author":"Detry, J.-M.R.; Decoster, P.M.; Brasseur, L.A.","year":"1983","unstructured":"Detry J-MR, Decoster PM, Brasseur LA. Hemodynamic effects of Corwin (ICI 118, 587), a new cardioselective beta-adrenoceptor partial agonist. Eur Heart 7 1983; 4: 584-91.","journal-title":"Eur Heart"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1136\/hrt.52.1.49","article-title":"The acute haemodynamic effects of oral prenalterol in severe heart failure","volume":"52","year":"1984","unstructured":"Petch MC, Wisbey C, Ormerod 0, Scott C, Goodfellow RM. The acute haemodynamic effects of oral prenalterol in severe heart failure. Br HeartJ 1984; 52: 49-52.","journal-title":"Br HeartJ"},{"key":"ref_18","article-title":"Tweddel AC. A controlled trial of oral prenalterol in patients with chronic cardiac failure","volume":"4","author":"Hutton, I.; Clark, R.S.; McKillop, J.H.; Martin, W.","year":"1983","unstructured":"Hutton I, Clark RS, McKillop JH, Martin W, Tweddel AC. A controlled trial of oral prenalterol in patients with chronic cardiac failure. Eur Heart J 1983; 4 (suppl E): 27.","journal-title":"Eur Heart J"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/clc.4960070106","article-title":"A dose response study with oral prenalterol in patients with chronic congestive cardiac failure","volume":"7","author":"Hendry, W.G.; Comerford, M.B.; Besterman, E.M.M.","year":"1984","unstructured":"Hendry WG, Comerford MB, Besterman EMM. A dose response study with oral prenalterol in patients with chronic congestive cardiac failure. Clin Cardiol 1984; 7: 23-8.","journal-title":"Clin Cardiol"},{"key":"ref_20","first-page":"13042","article-title":"Approaches to sudden death from coronary heart disease","volume":"44","author":"Lown, B.; Wolf, M.","year":"1971","unstructured":"Lown B, Wolf M. Approaches to sudden death from coronary heart disease. Circulation 1971; 44: 13042.","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0378-4347(00)84144-4","article-title":"Determination of prenalterol in plasma and in urine by gas-liquid chromatography","volume":"222","author":"Degen, P.H.; Ervik, M.","year":"1981","unstructured":"Degen PH, Ervik M. Determination of prenalterol in plasma and in urine by gas-liquid chromatography. J Chromatogr 1981; 222: 437-44.","journal-title":"J Chromatogr"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/hrt.43.2.134","article-title":"Haemodynamic effects of prenalterol in patients with coronary heart disease","volume":"43","author":"Hutton, I.; Murray, R.G.; Boyes, R.N.; Rae, A.P.; Hillis, W.S.","year":"1980","unstructured":"Hutton I, Murray RG, Boyes RN, Rae AP, Hillis WS. Haemodynamic effects of prenalterol in patients with coronary heart disease. Br Heart J 1980; 43: 134-7.","journal-title":"Br Heart J"},{"key":"ref_23","first-page":"107","article-title":"Prenalterol-a new cardioselective inotropic agent","volume":"7","author":"Kendall, M.J.; Goodfellow, R.M.; Westerling, S.","year":"1982","unstructured":"Kendall MJ, Goodfellow RM, Westerling S. Prenalterol-a new cardioselective inotropic agent. J Clin Hosp Pharm 1982; 7: 107-18.","journal-title":"J Clin Hosp Pharm"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/oxfordjournals.eurheartj.a061523","article-title":"Haemodynamic and cardiac metabolic effects of the new,81 agonist prenalterol in patients with cardiac failure","volume":"4","author":"Kupper, W.; Schutt, M.; Hamm, C.W.; Kuck, K.H.; Hanrath, P.; Bleifeld, W.","year":"1983","unstructured":"Kupper W, Schutt M, Hamm CW, Kuck KH, Hanrath P, Bleifeld W. Haemodynamic and cardiac metabolic effects of the new,81 agonist prenalterol in patients with cardiac failure. Eur Heart J 1983; 4: 573-83.","journal-title":"Eur Heart J"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1161\/01.CIR.66.2.361","article-title":"Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy","volume":"66","author":"Erbel, R.; Meyer, J.; Lambertz, H.","year":"1982","unstructured":"Erbel R, Meyer J, Lambertz H, et al. Hemodynamic effects of prenalterol in patients with ischemic heart disease and congestive cardiomyopathy. Circulation 1982; 66: 361-9.","journal-title":"Circulation"},{"key":"ref_26","first-page":"33","article-title":"Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure","volume-title":"AmJI Cardiol","volume":"47","author":"Franciosa, J.A.; Park, M.; Levine, T.B.","year":"1981","unstructured":"Franciosa JA, Park M, Levine TB. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. AmJI Cardiol 1981; 47: 33-9."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1161\/01.CIR.61.5.955","article-title":"Exercise capacity in patients with severe left ventricular dysfunction","volume":"61","author":"Benge, W.; Litchfield, R.L.; Marcus, M.L.","year":"1980","unstructured":"Benge W, Litchfield RL, Marcus ML. Exercise capacity in patients with severe left ventricular dysfunction. Circulation 1980; 61: 955-9.","journal-title":"Circulation"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.CIR.66.1.129","article-title":"Normal exercise capacity in patients with severe left ventricular dysfunction: compensatory mechanisms","volume":"66","author":"Litchfield, R.L.; Kerber, R.E.; Benge, J.W.","year":"1982","unstructured":"Litchfield RL, Kerber RE, Benge JW, et al. Normal exercise capacity in patients with severe left ventricular dysfunction: compensatory mechanisms. Circulation 1982; 66: 129-34.","journal-title":"Circulation"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.67.3.613","article-title":"Hemodynamic, hormonal and electrolyte responses to prenalterol infusion in heart failure","volume":"67","author":"Fitzpatrick, D.; Ikram, H.; Nicholls, M.G.; Espiner, E.A.","year":"1983","unstructured":"Fitzpatrick D, Ikram H, Nicholls MG, Espiner EA. Hemodynamic, hormonal and electrolyte responses to prenalterol infusion in heart failure. Circulation 1983; 67: 613-9.","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1056\/NEJM198107233050402","article-title":"Decreased lymphocyte beta-adrenergic receptor density in patients with heart failure and tolerance to the beta adrenergic agonist pirbuterol","volume":"305","author":"Colucci, W.S.; Alexander, R.W.; Williams, G.H.","year":"1981","unstructured":"Colucci WS, Alexander RW, Williams GH, et al. Decreased lymphocyte beta-adrenergic receptor density in patients with heart failure and tolerance to the beta adrenergic agonist pirbuterol. N Engl J Med 1981; 305: 185-90.","journal-title":"N Engl J Med"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1136\/hrt.44.2.117","article-title":"Beneficial effects of long-term beta-blockade in congestive cardiomyopathy","volume":"44","author":"Swedberg, K.; Hjalmarson, A.; Waagstein, F.; Wallentin, I.","year":"1980","unstructured":"Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br HeartJ 1980; 44: 117-33.","journal-title":"Br HeartJ"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/S0140-6736(81)90881-3","article-title":"Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy","volume":"ii:","author":"Ikram, H.; Fitzpatrick, D.","year":"1981","unstructured":"Ikram H, Fitzpatrick D. Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy. Lancet 1981; ii: 490-3.","journal-title":"Lancet"},{"issue":"34","key":"ref_33","first-page":"\"28","article-title":"Exercise tests. Comparison of the energy cost and heart rate response to five commonly-used singe-stage, non-steady-state, submaximal work procedures","volume":"4","author":"Blackburn, H.; Winkler, G.; Vilandre, J.; Hodgson, J.; Taylor, H.L.","year":"1970","unstructured":"Blackburn H, Winkler G, Vilandre J, Hodgson J, Taylor HL. Exercise tests. Comparison of the energy cost and heart rate response to five commonly-used singe-stage, non-steady-state, submaximal work procedures. In: Brunner D, Jokl E, eds. Physical actitvty and aging: with special reference to the effect of exercise and training on the natural history of arteriosclerotic heart disease. Basel: Karser, 1970: 28-36. (Medicine and Sport, Vol 4.) 34 Lambertz H, Meyer J, Erbel R. Long-term hemodynamic effects of prenalterol in patients with severe congestive heart failure. Circulation 1984; 69: 298-305.","journal-title":"(Medicine and Sport; actitvty and aging: with special reference to the effect of exercise and training on the natural history of arteriosclerotic heart disease"},{"key":"ref_34","first-page":"530","article-title":"Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure","volume":"1","author":"Currie, P.J.; Kelly, M.J.; Middlebrook, K.","year":"1984","unstructured":"Currie PJ, Kelly MJ, Middlebrook K, et al. Acute intravenous and sustained oral treatment with the beta1 agonist prenalterol in patients with chronic severe cardiac failure. Br HeartJ 1984; S1: 530-8.","journal-title":"Br HeartJ"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/hrt.53.2.208","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T00:59:10Z","timestamp":1601081950000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/hrt.53.2.208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,2,1]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1985,2,1]]}},"URL":"https:\/\/doi.org\/10.1136\/hrt.53.2.208","relation":{},"ISSN":["1355-6037"],"issn-type":[{"value":"1355-6037","type":"print"}],"subject":[],"published":{"date-parts":[[1985,2,1]]}}}